Jump to Main Contents
ncc en

Home > Information

Information

Nov. 5, 2024
NCC will initiate new research to develop a nationwide Clinical Trial Network, LC-SCRUM-CD (Clinical Development), supported by PREMIA and Paradigm, to further accelerate precision medicine for cancer patients.
Sep. 20, 2024
HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Receives Its First Regulatory Approval
Sep. 17, 2024
SCRUM-Japan GOZILA Confirms Extended Survival with Personalized Cancer Treatment in 4,000+ Patients Study
Sep. 17, 2024
CIRCULATE-Japan GALAXY Confirms Effectiveness of Liquid Biopsy in Predicting Recurrence Risk and Post-operative Treatment Efficacy in Colorectal Cancer
Sep. 12, 2024
Investigator-initiated clinical studies to be launched following confirmation of tumor shrinkage induced by the targeted protein degrader E7820 using J-PDX (Japanese cancer patient-derived tissue transplantation models)
Aug. 9, 2024
Start of Fecal Microbiota Transplantation Clinical Study for Esophageal and Gastric Cancer Patients
Aug. 6, 2024
Visit to National Cancer Institute
Aug. 1, 2024
Philippine Health Secretary’s Delegation Visited Tsukiji
Jul. 11, 2024
Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL)
Jun. 11, 2024
Collaborative Research for Advanced Data Linkage between Electronic Medical Records and Clinical Trial Data Collection System
Jun. 10, 2024
Dutch-Japanese workshop 'AI for Health' held
Jun. 10, 2024
Dr Tatsuhiro Shibata nominated Scientific Council Member of IARC
Jun. 4, 2024
NCC and PeptiDream Announce the First Dosing of 64Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma
May 14, 2024
World’s Largest Whole Genome Sequencing of Renal Cancer:
mutational signature linked to an unknown exposure discovered in 70% of Japanese samples
May 8, 2024
Chugai, NCCH, OMPU and MICIN Start Company-Sponsored Phase I Study in Oncology with a New Decentralized Clinical Trial Structure
Apr. 4, 2024
Delegation from Republic of Lithuania visited
Apr. 2, 2024
Leadership from the Taipei Economic and Cultural Representative Office (TECRO) in Japan visited
Mar. 19, 2024
National Health Commission of the PRC visited
Mar. 14, 2024
MoU signing ceremony with National Cancer Institute, Thailand
Mar. 8, 2024
WHO Regional Director for Western Pacific visited
Jan. 15, 2024
Result of a Japan-led International Investigator-Initiated Registration-Directed Trial Offers a New Treatment Option of Palbociclib in Combination with Tamoxifen
Jan. 12, 2024
Team explores role of STING – stimulator of interferon genes – in body’s innate immune system
Jan. 11, 2024
An Asian Multicenter Clinical Trial Evaluating Efficacy of
Computer-Aided Detection for Colonoscopy in Colorectal Cancer Screening